index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Duchenne DMD dystrophy Long noncoding RNA CaVβs Animal/physiopathology Inbred mdx Multi resolution modeling Metabolism Knockout Duchenne muscular dystrophy DMD Dystrophie Musculaire de Becker BMD Cell Line Dystrophy Energy Metabolism/drug effects Muscle Myotendinous junction Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Human Umbilical Vein Endothelial Cells Molecular Sequence Data Inhibitors MES Dystrophine Myogenesis Becker muscular dystrophy BMD Calcium Autophagy Activin Receptors CaV subunits Muscle development Muscles/physiopathology Muscle Strength Male Epigenetics Cardiomyopathie Skeletal muscle Molecular docking Modificateurs de gènes Homeostasis Dynamin 2 NAD+ Gene Expression Regulation/drug effects MiARN Mdx mouse Génomique Muscular dystrophy Duchenne muscular dystrophy Invivo Gene expression Cells Centronuclear myopathy Muscle Biology Delivery NNOS Muscular Dystrophy CD38 LKB1 Calcium Channels L-Type Inbred C57BL Mitochondrial fission DMO BMD Cell homeostasis DMD Dystrophin Long QT Hear Becker muscular dystrophy Diseases Clinical trials Multi exon skipping Cell Biology Genomic Exon skipping Cardiomyopathy Dystrophin-EGFP Allele‐specific silencing therapy Morphogenesis Cachexia LncARN DHPR α1S Muscular Atrophy Ex-vivo Liver Base Sequence Drp1 Dystrophin central domain Hepatocellular carcinoma Gene modifiers LncRNA Dystrophie musculaire de Becker Humans CTNNB1 Mice Multiresolution modeling Becker BMD muscular dystrophy Dystrophie Musculaire de Duchenne DMD Animals Antisense oligonucleotides Immunoglobulin Fc Fragments/pharmacology Cultured